Study Extends Potential of Personalized Cell-based Immunotherapies

News   Mar 16, 2018 | Original story from Ludwig Institute for Cancer Research

 
Study Extends Potential of Personalized Cell-based Immunotherapies

Shown here is a pseudo-colored scanning electron micrograph of an oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red), part of a natural immune response. Credit: Rita Elena Serda, NCI/Duncan Comprehensive Cancer Center at Baylor College of Medicine

 
 
 

RELATED ARTICLES

Key Role for Enzyme in Chagas Disease Response

News

Researchers describe the central role played by an enzyme called phosphatidylinositol 3-kinase gamma (PI3Kγ) in regulating the immune response against Trypanosoma cruzi, the protozoan parasite that causes Chagas disease.

READ MORE

Testosterone Effective at Combating Cachexia in Cancer Patients

News

Many cancer patients suffer from a loss of body mass known as cachexia. A new study shows that the hormone testosterone is effective at combatting cachexia in cancer patients and improving quality of life.

READ MORE

Three-Cell Ignition Required

News

New research shows that NK-cell recruitment and activation requires a rather carefully choreographed interaction of three cell types in the headquarters of the slower adaptive immune-activation: the lymph node.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy